Evidence map›Paper›PMID 36579592›Full record

ArticleJournal of personalized medicine2022

Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family.

Catherine A Dennen, Kenneth Blum, Abdalla Bowirrat, Panayotis K Thanos, Igor Elman, Mauro Ceccanti, Rajendra D Badgaiyan, Thomas McLaughlin, Ashim Gupta, Anish Bajaj and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A Comprehensive 4-layeredCurrent pharmaceutical biotechnology · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Are We Getting High Cause the Thrill is Gone?Journal of addiction psychiatry · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 5 countries.

Catherine A DennenDepartment of Family Medicine, Jefferson Health Northeast, Philadelphia, PA 08033, USA.
Kenneth BlumDivision of Addiction Research & Education, Center for Sports and Mental Health, Western University of Health Sciences, Pomona, CA 91766, USA.ORCID 0000-0001-6727-803X
Abdalla BowirratDepartment of Molecular Biology and Adelson School of Medicine, Ariel University, Ariel 40700, Israel.ORCID 0000-0001-8185-0688
Panayotis K ThanosBehavioral Neuropharmacology and Neuroimaging Laboratory, Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14203, USA.
Igor ElmanCenter for Pain and the Brain (P.A.I.N Group), Department of Anesthesiology, Critical Care & Pain Medicine, Boston Children's Hospital, Boston, MA 02115, USA.
Mauro CeccantiSocietà Italiana per il Trattamento dell'Alcolismo e le sue Complicanze (SITAC), ASL Roma, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0001-9981-8715
Rajendra D BadgaiyanDepartment of Psychiatry, South Texas Veteran Health Care System, Audie L. Murphy Memorial VA Hospital, Long School of Medicine, University of Texas Medical Center, San Antonio, TX 78229, USA.ORCID 0000-0001-5586-5114
Thomas McLaughlinReward Deficiency Clinics of America, Austin, TX 78701, USA.
Ashim GuptaFuture Biologics, Lawrenceville, GA 30043, USA.ORCID 0000-0003-1224-2755
Anish BajajBajaj Chiropractic Clinic, New York, NY 10010, USA.ORCID 0000-0002-7079-6740
David BaronDivision of Addiction Research & Education, Center for Sports and Mental Health, Western University of Health Sciences, Pomona, CA 91766, USA.
B William DownsDepartment of research and development, Victory Nutrition International, Inc., Bonita, Springs,FL 34035, USA.ORCID 0000-0003-2096-8265
Debasis BagchiDepartment of Pharmaceutical Sciences, Texas Southern University College of Pharmacy and Health Science,Houston, TX 77004, USA.ORCID 0000-0001-9478-6427
Mark S GoldDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA.
Ariel University · ILASL Roma · ITBoston Children's Hospital · USEötvös Loránd University · HUTexas Medical Center · USTexas Southern University · USThomas Jefferson University Hospital · USWashington University in St. Louis · USWestern University of Health Sciences · US

Funding

Dopamine Neurotransmission in Tourette SyndromeR01NS073884 · NINDS · UNIVERSITY OF MINNESOTA · PI BADGAIYAN, RAJENDRA D · 2012 to 2016
$2.2M
A Systematic Medical Approach to Reward Transformation (SMART) for Brain Health in Opioid Use DisorderR41MD012318 · NIMHD · VERSA INTEGRATED SOLUTIONS, INC. · PI BLUM, KENNETH, GONDRE-LEWIS, MARJORIE C · 2017 to 2017
$221k
Dr. Blum and Marjorie Gondre-Lewis (Howard University), NIH recipients of R41 MD012318/ MD/NIMHD NIH HHS/United States. R.D.B. is the recipient of NIH R01NS073884. NANIMHD NIH HHS R41 MD012318NINDS NIH HHS R01 NS073884
6 · The paper itself

Abstract

This case series presents the novel genetic addiction risk score (GARS), which shows a high prevalence of polymorphic risk alleles of reward genes in a nuclear family with multiple reward deficiency syndrome (RDS) behavioral issues expressing a hypodopaminergic antecedent. The family consists of a mother, father, son, and daughter. The mother experienced issues with focus, memory, anger, and amotivational syndrome. The father experienced weight issues and depression. The son experienced heavy drinking, along with some drug abuse and anxiety. The daughter experienced depression, lethargy, brain fog, focus issues, and anxiety, among others. A major clinical outcome of the results presented to the family members helped reduce personal guilt and augment potential hope for future healing. Our laboratory's prior research established that carriers of four or more alleles measured by GARS (

Indexed as

genetic addiction risk severity (GARS)hypodopaminergiapolymorphismsreward circuitryreward deficiency syndrome (RDS)single nucleotide polymorphisms (SNPs)

Identifiers

PMID36579592
PMCPMC9694640
OpenAlexW4308507745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.